• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Teva Pharmaceutical Industries

Teva Pharmaceutical Industries

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Research
  1. Mayne Pharma Buys US Drugs from Teva , Allergan for $652 Million

    Mayne Pharma Buys US Drugs from Teva , Allergan for $652 Million

  2. Hormone Replacement Therapy (HRT) - Global Strategic Business Report 2016-2022: Amid Controversies, Confusion and Competition, Demand for HRT Continues to Rise - Research and Markets

    Hormone Replacement Therapy (HRT) - Global Strategic Business Report 2016-2022: Amid Controversies, Confusion and Competition, Demand for HRT Continues to Rise - Research and Markets

  3. Dr. Reddy’s to acquire product portfolio from TEVA for US Market

    Dr. Reddy’s to acquire product portfolio from TEVA for US Market

  4. Dr. Reddy's Buying Eight Drugs From Teva for U.S. Market

    Dr. Reddy's Buying Eight Drugs From Teva for U.S. Market

  5. Business Watch -- WSJ

    Business Watch -- WSJ

  6. $39.4 Billion Biomarkers Report: Technologies and Global Markets to 2020 - Research and Markets

    $39.4 Billion Biomarkers Report: Technologies and Global Markets to 2020 - Research and Markets

  7. UGG and Law Enforcement Unearth Bonanza of Fakes

    UGG and Law Enforcement Unearth Bonanza of Fakes

  8. Lilly: German Supreme Court Grants Appeal in Dispute With Actavis

    Lilly: German Supreme Court Grants Appeal in Dispute With Actavis

  9. Technavio Announces Top Ten Vendors in the Global Chronic Lymphocytic Leukemia Market from 2016 to 2020

    Technavio Announces Top Ten Vendors in the Global Chronic Lymphocytic Leukemia Market from 2016 to 2020

  10. Sosei Appoints Peter Bains as CEO

    Sosei Appoints Peter Bains as CEO

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.